Wieslaw Bal

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Immunology Immunology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (10)

Paweł Sobczuk

Medical University of Warsaw

POLAND

View details

Anetta Lasek-Bal

Medical University of Silesia

POLAND

View details

Rafal Suwinski

Chair/Professor

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Kamil Drucis

Medical University of Gdansk

POLAND

View details

Anna Czarnecka

Professor

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Magdalena Olbryt

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Wieslawa Widlak

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Magdalena Rosińska

current position: Head of Department

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Bozena Cybulska-Stopa

Chief

Wrocław University of Scince and Technology

POLAND

View details

Przemyslaw Puz

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Wieslaw Bal

Research Interests

Explore related searches

Contact this professor

Articles (11)

Melanoma genomics – will we go beyond BRAF in clinics?

Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report

Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment

Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma.

Relevance of admission hyperglycaemia and diabetes mellitus to efficacy and safety of mechanical thrombectomy in stroke patients

Characteristics of Giant Nodular Melanomas in Special Locations: a Case Series and Review of the Literature

The role of enzalutamide in the treatment of prostate cancer from the perspective of Polish oncologists

Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients

Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients—Real-World Evidence

Clinical and Non-Clinical Determinants of the Effect of Mechanical Thrombectomy and Post-Stroke Functional Status of Patients in Short and Long-Term Follow-Up

NGS Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Melanoma Samples Using Oncomine™ Pan-Cancer Cell-Free Assay.

Collaborators (10)

Paweł Sobczuk

Anetta Lasek-Bal

Rafal Suwinski

Kamil Drucis

Anna Czarnecka

Magdalena Olbryt

Wieslawa Widlak

Magdalena Rosińska

Bozena Cybulska-Stopa

Przemyslaw Puz

Make your next move.